Board of Directors

Gerald Möller

Gerald Möller

Chairman of the Board
He has over 40 years’ experience in the pharmaceutical and diagnostics industry. He served as CEO in Boehringer Mannheim and as Head of Development and Strategic Marketing Pharmaceuticals in Roche. He has been an investment advisor at HBM Partners for 12 years. He was also a board member with Illumina Inc. until 2015. Currently he is in the Board of various Life Science companies.
Andrea Senaldi

Andrea Senaldi

CEO
Seasoned executive with more than 10 years experience in the IVD industry. Between 2004 and 2011 he has been SVP and CFO of DiaSorin an outperforming company in IVD. Prior to that, he has covered several executive positions at Unilever. More recently, he gathered additional experience with early stage Medtech companies, as Managing Partner at Valuemaze, an advisor to SMEs on strategy definition/deployment and M&A execution. Degree in economics and finance.
Diana Saraceni

Diana Saraceni

Member of the Board
She is Founder and Managing Partner of Panakes Partners SGR one of the major Med Tech venture investors in Europe. She brings almost 20 years of experience in Venture Capital investments on a large portfolio of successful companies in Italy and Europe.
Francesco Granata

Francesco Granata

Member of the Board
He is Chairman of Circassia LtD. Francesco is Senior Advisor at Warburg Pincus. Prior, he was Executive VP at Biogen Idec, and Group VP and President for Canada and European markets at Schering-Plough Corporation. He served as Regional President for Northern Europe, Middle East and Africa at Pfizer. Currently a Board member of Italfarmaco SpA, pharmaceutical and chemical leading Italian group, Prismic Pharmaceuticals, Quanta, and a member of the strategic advisory committee at Lupin, an Indian global pharmaceutical company.
Maurizio Memo

Prof. Maurizio Memo

Member of the Board
He is Co-Founder and Scientific Advisor of Diadem. He is Professor at the University of Brescia (Molecular and Translational Medicine Department), recognised for his very impactful contribution to the field of neurodegeneration and the role of DNA damage and repair mechanisms and the molecular basis of amyloid beta pathogenesis and pharmacology, in the context of neurodegeneration.
Simona Piccirella

Simona Piccirella

PhD, VP Product Development and Operations
PhD, VP Product Development and Operations Experienced manager with profound knowledge of life science sector. In 2009 she co-founded the company VisMederi srl and she was COO until 2016, serving clients such as Sanofi, Novartis, GSK, Takeda in vaccine immunogenicity evaluation and analytical assay validation.
Antonio Boniolo

Antonio Boniolo

Member of the Board
He served as CEO of DiaSorin SpA, a multinational diagnostics company of 4.1 billion $ market cap. He led the company through growth and brings over thirty years of experience in operational, technical and business aspects in the IVD sector. Currently co-founder and Chairman of Jointherapeutics Srl, a start-up Company focused at developing innovative approaches for the management of osteoarticular pathologies.